Search research articles
Contact Us
Filters
Showing results (391-400 of 463) with videos related to
Page
of 47
Sort By:
Inflammatory Bowel Diseases
|
April 29, 2025
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies
Stefan Schreiber, Jean-Frederic Colombel, Stephen B Hanauer, et al.
Gastroenterology
|
June 23, 2026
Proactive Fecal Calprotectin Home Monitoring in Ulcerative Colitis: Results of a Prospective Randomized Control Trial
Gregory Rosenfeld, Neeraj Narula, Yvette Leung, et al.
United European Gastroenterology Journal
|
October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective
Tommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
The Journal of Experimental Medicine
|
December 12, 2024
Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis
Joan Shang, Diane Marie Del Valle, Graham J Britton, et al.
Gut
|
August 9, 2024
Age-related patterns of microbial dysbiosis in multiplex inflammatory bowel disease families
Jonathan P Jacobs, Elizabeth A Spencer, Drew S Helmus, et al.
Nature Immunology
|
July 30, 2024
A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycan
Joana Gaifem, Cláudia S Rodrigues, Francesca Petralia, et al.
The Journal of Clinical Investigation
|
May 2, 2023
Selective IgA2 deficiency in a patient with small intestinal Crohn's disease
Pablo Canales-Herrerias, Yolanda Garcia-Carmona, Joan Shang, et al.
The Lancet. Gastroenterology & Hepatology
|
January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
Edouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Gastroenterology
|
December 12, 2018
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Sudarshan Paramsothy, Shaun Nielsen, Michael A Kamm, et al.
The Lancet. Gastroenterology & Hepatology
|
April 5, 2025
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design
Sailish Honap, Nelly Agrinier, Joana Torres, et al.
Page
of 47
Search research articles
Search
Showing results (391-400 of 463) with videos related to
Sort By:
Page
of 47
Inflammatory Bowel Diseases
|
April 29, 2025
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies
Stefan Schreiber, Jean-Frederic Colombel, Stephen B Hanauer, et al.
Gastroenterology
|
June 23, 2026
Proactive Fecal Calprotectin Home Monitoring in Ulcerative Colitis: Results of a Prospective Randomized Control Trial
Gregory Rosenfeld, Neeraj Narula, Yvette Leung, et al.
United European Gastroenterology Journal
|
October 5, 2024
Defining mucosal healing in randomized controlled trials of inflammatory bowel disease: A systematic review and future perspective
Tommaso Lorenzo Parigi, Virginia Solitano, Alessandro Armuzzi, et al.
The Journal of Experimental Medicine
|
December 12, 2024
Baseline colitogenicity and acute perturbations of gut microbiota in immunotherapy-related colitis
Joan Shang, Diane Marie Del Valle, Graham J Britton, et al.
Gut
|
August 9, 2024
Age-related patterns of microbial dysbiosis in multiplex inflammatory bowel disease families
Jonathan P Jacobs, Elizabeth A Spencer, Drew S Helmus, et al.
Nature Immunology
|
July 30, 2024
A unique serum IgG glycosylation signature predicts development of Crohn's disease and is associated with pathogenic antibodies to mannose glycan
Joana Gaifem, Cláudia S Rodrigues, Francesca Petralia, et al.
The Journal of Clinical Investigation
|
May 2, 2023
Selective IgA2 deficiency in a patient with small intestinal Crohn's disease
Pablo Canales-Herrerias, Yolanda Garcia-Carmona, Joan Shang, et al.
The Lancet. Gastroenterology & Hepatology
|
January 14, 2023
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial
Edouard Louis, Matthieu Resche-Rigon, David Laharie, et al.
Gastroenterology
|
December 12, 2018
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Sudarshan Paramsothy, Shaun Nielsen, Michael A Kamm, et al.
The Lancet. Gastroenterology & Hepatology
|
April 5, 2025
Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design
Sailish Honap, Nelly Agrinier, Joana Torres, et al.
Page
of 47